These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28942989)

  • 1. Effects of Transdermal Tulobuterol in Pediatric Asthma Patients on Long-Term Leukotriene Receptor Antagonist Therapy: Results of a Randomized, Open-Label, Multicenter Clinical Trial in Japanese Children Aged 4-12 Years.
    Katsunuma T; Fujisawa T; Mizuho N; Akira A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
    Allergol Int; 2013; 62(1):37-43. PubMed ID: 28942989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
    Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
    Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
    Hozawa S; Haruta Y; Terada M; Yamakido M
    Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
    Burioka N; Miyata M; Endo M; Fukuoka Y; Suyama H; Nakazaki H; Igawa K; Shimizu E
    Chronobiol Int; 2005; 22(2):383-90. PubMed ID: 16021849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy and safety of tulobuterol tape in mild and moderate persistent asthma patients].
    Su N; Lin JT; Yang M; Chen X; He J; He QY; Cao ZL; Chen BY; Xiao Y; Yan XX
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):39-42. PubMed ID: 17331388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
    Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
    Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
    Kanehara M; Yokoyama A; Tomoda Y; Shiota N; Iwamoto H; Ishikawa N; Taooka Y; Haruta Y; Hattori N; Kohno N
    Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
    Lin Q; Liu QH; Bao YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children.
    Kondo N; Katsunuma T; Odajima Y; Morikawa A
    Allergol Int; 2006 Sep; 55(3):287-93. PubMed ID: 17075269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
    Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
    Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.
    Nathan RA; Minkwitz MC; Bonuccelli CM
    Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
    Yamagata T; Hirano T; Sugiura H; Yanagisawa S; Ichikawa T; Ueshima K; Akamatsu K; Nakanishi M; Matsunaga K; Minakata Y; Ichinose M
    Pulm Pharmacol Ther; 2008; 21(1):160-5. PubMed ID: 17632023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of tulobuterol aerosol in childhood asthma.
    Sienra-Monge JJ; Graham-Zapata LF; Del Rio-Navarro BE
    J Int Med Res; 1990; 18(6):483-8. PubMed ID: 2292330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.